Related Topics News -

     
 Title only   |   Print    Next page > 
     
《港股》恆指半日跌95點 匯控升1% 華虹挫逾半成 SK海力士槓桿ETF急挫18%

2026-10-13T  
《大行》摩通:不太擔心利率上升影響中國醫療健康行業 繼續看好生物科技及CXO

2026-10-06T  
《大行》高盛對醫藥及生物科技股投資評級及目標價(表)

2026-09-30T  
《大行》高盛:亞洲CDMO需求可見性提升 看好涉足早期研發及新興療法企業

2026-09-30T  
《輪動華泰》貼息政策落地內房股回軟 金斯瑞升一成破頂

2026-09-30T  
《大行》高盛:藥明合聯商業化生產驗證成為長期能見度關鍵催化劑

2026-09-25T  
《大行》摩通:美國財政部或容許大部分中國醫藥對外授權交易 正關注「COINS法案」措辭

2026-09-22T  
《大行》野村:中國醫藥「十五五」規劃突出創新與全球化 利好創新藥企及CRDMO

2026-09-21T  
《大行》大摩:藥明合聯重申收入目標 維持「增持」評級

2026-09-18T  
內地十部門印發醫藥工業「十五五」規劃 2030年營收目標不少於3.5萬億人幣

2026-09-18T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.